Olmesartan Plus Tablet 20/12.5 Milligrams
Olmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
MFDS item code 201101023 · Approved 2011.02.28
This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
This medication is used when blood pressure control is insufficient with olmesartan medoxomil or hydrochlorothiazide monotherapy in patients with essential hypertension. It effectively lowers blood pressure, reduces the risk of cardiovascular disease, and helps maintain a healthy blood pressure state. Therefore, it is used for the treatment of essential hypertension.
Before administering this drug, it is recommended that the doses of olmesartan medoxomil or hydrochlorothiazide be adjusted individually. If blood pressure is not adequately controlled with the individual components, administer 1 tablet of this drug once daily, with or without food. Adjust the dose at intervals of 2~4 weeks based on the patient's blood pressure response. A marked blood pressure-lowering effect may occur when olmesartan medoxomil is added or when switching to this drug (olmesartan medoxomil/hydrochlorothiazide) in patients taking high doses of hydrochlorothiazide alone and in patients with volume depletion or hyponatremia. In such cases, reduce the hydrochlorothiazide dose to 12.5 mg before adding olmesartan medoxomil. <Elderly patients> In elderly patients, start with the lowest dose and use caution when adjusting the dose, taking into consideration the patient's renal or cardiac function, comorbidities, and other concomitant medications. <Patients with renal impairment> This drug (olmesartan medoxomil/hydrochlorothiazide) is generally administered to patients with mild to moderate renal impairment (creatinine clearance>30mL/min). Do not administer this drug (olmesartan medoxomil/hydrochlorothiazide) to patients with more severe renal impairment, for whom loop diuretics are preferable to thiazide diuretics. <Patients with hepatic impairment> Use of this drug is not recommended in patients with hepatic impairment because there is no experience with its use in these patients.
Safety and efficacy in pediatric patients have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Those who have an allergic reaction to this medication, hypersensitivity to certain diuretics, significant impairment of kidney or liver function, or those who are pregnant or breastfeeding should not take this medication. Patients with reduced blood volume or electrolyte imbalance, kidney or liver disease, heart disease, or certain endocrine disorders should use this medication with special caution. Dizziness or hypotension may occur while taking this medication, so patients' conditions should be closely monitored during the initiation of treatment, and appropriate measures should be taken as needed. This medication may affect potassium levels, so blood potassium levels must be carefully monitored when taken with potassium supplements or potassium-sparing diuretics. Care must be taken when used in conjunction with other antihypertensive medications, as it can increase the blood pressure-lowering effect. This medication may increase the risk of kidney function deterioration or toxicity when combined with certain anti-inflammatory pain relievers or lithium, so discuss with a doctor before taking these medications together. This medication may make the skin sensitive to sunlight, so it is advisable to avoid prolonged sun exposure and use sunscreen as necessary. If allergic reactions such as skin rash, itching, or difficulty breathing occur during use, discontinue use immediately and inform healthcare personnel. The safety and efficacy of this medication have not been established for use in children, so it is best not to administer it to children. Elderly patients may have a risk of decreased kidney and liver function, so it is advisable to start at the lowest dose and adjust the dosage carefully based on the patient's condition. In case of overdose, symptoms such as hypotension, electrolyte imbalance, and dehydration may occur, and appropriate treatment should be sought immediately. It is important to regularly monitor blood pressure, kidney function, and electrolyte levels during treatment to ensure there are no abnormalities.
Nausea, hyperuricemia, dizziness, upper respiratory infection, headache, urinary tract infection, chest pain, low back pain, peripheral edema, vertigo, abdominal pain, dyspepsia, gastroenteritis, diarrhea, elevated AST, elevated GGT, elevated ALT, hyperlipidemia, elevated creatine phosphokinase, hyperglycemia, arthritis, arthralgia, myalgia, cough, rash, hematuria, facial edema, asthenia, angioedema, anaphylactic reaction, vomiting, hair loss, pruritus, urticaria, hyponatremia, polyuria, palpitations, hypertension, epistaxis, asthma, fatigue, drowsiness, emotional blunting, restlessness, interstitial pneumonia, pulmonary edema, acute respiratory distress syndrome, orthostatic hypotension, arrhythmia, transient blurred vision, jaundice, hepatitis, acute cholecystitis, necrotizing vasculitis, interstitial pneumonia, facial flushing, anaphylaxis, acute kidney injury, interstitial nephritis, renal impairment, lethargy, nasal congestion, erectile dysfunction, exacerbation of systemic lupus erythematosus, parathyroid disorder, muscle cramps, sensory abnormalities, weakness, Stevens-Johnson syndrome, erythema multiforme, exfoliative dermatitis, toxic epidermal necrolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or moisture, preferably at room temperature between 1 degree and 25 degrees. Storing it this way helps maintain the medication's effectiveness and prevent degradation.
Round film-coated tablets with a light orange color
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
Olmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Prescription medication · Combination
Kookje Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.